全氟壬酸铵 | 4149-60-4

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 卤代烷
• 中文名称: 全氟壬酸铵
• 中文别名: 3H-1,2,4-三唑-3-酮,5-氨基-2,4-二氢-2,4-二甲基-,腙
• 英文名称: Ammonium perfluorononanoate
• 英文别名: azanium;2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononanoate
• CAS: 4149-60-4
• 化学式: C9H4F17NO2
• 分子量: 481.11
• InChiKey: ORBBVPFDROYXQS-UHFFFAOYSA-N

物化性质

• 熔点：
  >180°C (dec.)
• 溶解度：
  可溶于氯仿（少许）、DMSO（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  5.24
• 重原子数：
  29
• 可旋转键数：
  7
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  38.3
• 氢给体数：
  2
• 氢受体数：
  20

安全信息

• 海关编码：
  2915900090

文献信息

• [EN] QUINOLINE INHIBITORS OF RAD52 AND METHODS OF USE<br/>[FR] INHIBITEURS DE LA QUINOLÉINE DE RAD52 ET MÉTHODES D'UTILISATION
  申请人：UNIV DREXEL

  公开号：WO2021067604A1

  公开（公告）日：2021-04-08

  The present disclosure related to compounds of Formula I and Formula I and to their pharmaceutically acceptable salts, pharmaceutical compositions, methods of use, and methods for their preparation. The compounds disclosed herein are useful for modulating RAD51 activity and may be used in the treatment of disorders in which RAD51 activity is implication, such as a cancer.

  本公开涉及到Formula I和Formula I的化合物及其药用盐、药物组合物、使用方法和制备方法。本文披露的化合物可用于调节RAD51活性，并可用于治疗RAD51活性参与的疾病，如癌症。
• Fluoroalkanesulfonyl azide monomers and copolymers thereof
  申请人：——

  公开号：US20020049343A1

  公开（公告）日：2002-04-25

  Fluorinated olefins and fluorinated vinyl ethers, each having sulfonyl azide groups, are useful monomers in preparing fluoropolymers having functional side groups. Such functional side groups are useful in curing the fluoropolymers and also for enhancing the adhesion of the fluoropolymers to other substrates.

  含有磺酰叠氮基团的氟代烯烃和氟代乙烯醚是制备具有功能侧基的氟聚合物的有用单体。这些功能侧基对于固化氟聚合物和增强氟聚合物与其他基材的粘附性都很有用。
• Selective JAK2 Pseudokinase Ligands and Methods of Use
  申请人：YALE UNIVERSITY

  公开号：US20220112166A1

  公开（公告）日：2022-04-14

  The compounds of Formula I described herein regulate activity of JAK2 by specifically binding to the JAK2 pseudokinase domain, JH2, and are useful as therapeutic agents in the treatment or amelioration of myeloproliferative disorders. Also provided herein are methods of treating myeloproliferative disorders, and methods of making compounds of Formula I.

  本文中描述的I式化合物通过特异性结合JAK2伪激酶结构域JH2来调节JAK2的活性，并可用作治疗或改善骨髓增生性疾病的治疗剂。此外，本文还提供了治疗骨髓增生性疾病的方法以及制备I式化合物的方法。
• [EN] MACROPHAGE MIGRATION INHIBITORY FACTOR INHIBITORS, AND METHODS OF MAKING AND USING SAME<br/>[FR] INHIBITEURS DU FACTEUR INHIBITEUR DE LA MIGRATION DES MACROPHAGES, ET LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION
  申请人：UNIV YALE

  公开号：WO2022093817A1

  公开（公告）日：2022-05-05

  The present disclosure provides inhibitors of MIF tautomerase activity. In certain embodiments, the compounds inhibitors are useful in treating or preventing inflammatory and/or auto-immune diseases. In other embodiments, the compounds are useful in reversing, ameliorating, and/or preventing tumor growth. In yet other embodiments, the compounds are useful in reversing, ameliorating, and/or preventing angiogenesis.

  本公开提供了MIF异构酶活性抑制剂。在某些实施例中，这些化合物抑制剂在治疗或预防炎症和/或自身免疫性疾病方面是有用的。在其他实施例中，这些化合物在逆转、改善和/或预防肿瘤生长方面是有用的。在另一些实施例中，这些化合物在逆转、改善和/或预防血管生成方面是有用的。
• Bisaminophenyl-based curatives and amidine-based curatives and cure accelerators for perfluoroelastomeric compositions
  申请人：Greene, Tweed of Delaware, Inc.

  公开号：US20040214956A1

  公开（公告）日：2004-10-28

  Novel monoamidine, monoamidoxime and bisamidine curatives, co-curatives and cure accelerators are provided for use with perfluoroelastomeric compositions as well as novel synthesis methods for making monoamidine- and monoamidoxime-based curatives, co-curatives and cure accelerators. Also provided are diphenyl-based curatives, co-curatives and cure accelerators having sufficiently high molecular weight such that the melting temperature of the curatives, co-curatives and cure accelerators is no greater than about 240° C., and more preferably no greater than about 230° C.

  本发明提供了用于与全氟弹性体组合物一起使用的新型单氨基咪唑、单氨基肟和双咪唑治疗剂、共同治疗剂和治疗加速剂，以及用于制备基于单氨基咪唑和单氨基肟的治疗剂、共同治疗剂和治疗加速剂的新型合成方法。还提供了二苯基基治疗剂、共同治疗剂和治疗加速剂，其分子量足够高，使得治疗剂、共同治疗剂和治疗加速剂的熔点不大于约240℃，更好地不大于约230℃。